NC Medicaid has approved codes for COVID-19-related medically necessary laboratory testing and has completed adding these services in NCTracks. Please note there are other codes currently under review that will be posted at a later date.
Topics Related to COVID-19
Select provider types enrolled in the NC Medicaid Program are required to file annual Medicaid cost reports utilizing cost reporting schedules which are based on approved Medicare cost reporting platforms.
This bulletin updates and extends NC Medicaid’s reimbursement for allowable COVID-19 testing of nursing facility staff and healthcare personnel.
This information is only for non-long-term care providers who have the means to handle the specific storage recommendations required of the Moderna COVID-19 vaccine and will be administering it.
This bulletin revises the COVID-Response Site criteria established in SPECIAL BULLETIN COVID-19 #82.
Following the Oct. 30, 2020, announcement that the NCTracks secure portal is live, providers are encouraged to submit qualifying COVID-19 related primary care services claims for reimbursement through the NCTracks secure portal.
For facilities using a point-of-care antigen test device for detection of SARS-CoV-2, this is a reminder that providers are required by State Health Director Order to report all results, positive and negative, of diagnostic testing for SARS-CoV-2, the virus that causes COVID-19.
The portal for providers to request reimbursement for COVID-19 related primary care services for uninsured individuals is live and can be accessed through the NCTracks secure portal.
Consistent with the federal Department of Health and Human Services’ extension of the federal COVID-19 Public Health Emergency to January 21, 2021, NC Medicaid is extending COVID-19 temporary provider rate increases and clinical coverage policies to that same date.
The US Department of Health and Human Services announced an additional funding opportunity for Medicaid/CHIP providers to apply for federal Provider Relief Funds. The application period runs through Nov. 6, 2020.